Varenicline: cardiovascular safety
- PMID: 21896709
- PMCID: PMC3168639
- DOI: 10.1503/cmaj.111-2073
Varenicline: cardiovascular safety
Comment on
-
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.CMAJ. 2011 Sep 6;183(12):1359-66. doi: 10.1503/cmaj.110218. Epub 2011 Jul 4. CMAJ. 2011. PMID: 21727225 Free PMC article.
References
-
- European Medicine Agency Press Release European Medicines Agency confirms positive benefit–risk balance for Champix. Benefits as a smoking-cessation medicine outweigh slight reported increase in cardiovascular events. Available: www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/... (accessed 2011 July 25).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources